AXOGEN INC (AXGN) Stock Price, Quote, News and Overview
NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD
AXGN Quote, Performance and Key Statistics
17.13
+0.65 (+3.94%)
The current stock price of AXGN is 17.13 USD. In the past month the price increased by 0.53%. In the past year, price increased by 195.86%.
AXGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.79 | 230.35B | ||
| ISRG | INTUITIVE SURGICAL INC | 69.3 | 189.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.86 | 155.20B | ||
| SYK | STRYKER CORP | 30.19 | 144.36B | ||
| MDT | MEDTRONIC PLC | 15.89 | 108.82B | ||
| BDX | BECTON DICKINSON AND CO | 11.98 | 48.46B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.1 | 44.47B | ||
| IDXX | IDEXX LABORATORIES INC | 41.39 | 38.24B | ||
| RMD | RESMED INC | 26.43 | 35.18B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.33 | 32.29B | ||
| DXCM | DEXCOM INC | 49.47 | 32.00B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.3 | 24.05B |
Related stock screener links
About AXGN
Company Profile
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 451 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Company Info
AXOGEN INC
Suite 100, 13859 Progress Blvd.
Alachua FLORIDA 32615 US
CEO: Karen Zaderej
Employees: 452
Phone: 13864626817
AXOGEN INC / AXGN FAQ
What is the stock price of AXOGEN INC today?
The current stock price of AXGN is 17.13 USD. The price increased by 3.94% in the last trading session.
What is the ticker symbol for AXOGEN INC stock?
The exchange symbol of AXOGEN INC is AXGN and it is listed on the Nasdaq exchange.
On which exchange is AXGN stock listed?
AXGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AXOGEN INC stock?
14 analysts have analysed AXGN and the average price target is 26.65 USD. This implies a price increase of 55.56% is expected in the next year compared to the current price of 17.13. Check the AXOGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AXOGEN INC worth?
AXOGEN INC (AXGN) has a market capitalization of 759.54M USD. This makes AXGN a Small Cap stock.
How many employees does AXOGEN INC have?
AXOGEN INC (AXGN) currently has 452 employees.
What are the support and resistance levels for AXOGEN INC (AXGN) stock?
AXOGEN INC (AXGN) has a support level at 15.57 and a resistance level at 17.14. Check the full technical report for a detailed analysis of AXGN support and resistance levels.
Is AXOGEN INC (AXGN) expected to grow?
The Revenue of AXOGEN INC (AXGN) is expected to grow by 16.31% in the next year. Check the estimates tab for more information on the AXGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AXOGEN INC (AXGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AXGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AXGN, evaluating the profitability, health, valuation and growth aspects
- AXOGEN INC (AXGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AXOGEN INC (AXGN) Sales and EPS estimates to see what analysts future expectations are.
- AXOGEN INC (AXGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AXOGEN INC (AXGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- AXOGEN INC (AXGN) Stock Chart to make your own analysis
- AXOGEN INC (AXGN) Latest news and press-releases to stay up to date.
Does AXOGEN INC (AXGN) stock pay dividends?
AXGN does not pay a dividend.
When does AXOGEN INC (AXGN) report earnings?
AXOGEN INC (AXGN) will report earnings on 2025-05-08, before the market open.
What is the Price/Earnings (PE) ratio of AXOGEN INC (AXGN)?
The PE ratio for AXOGEN INC (AXGN) is 131.77. This is based on the reported non-GAAP earnings per share of 0.13 and the current share price of 17.13 USD. Check the full fundamental report for a full analysis of the valuation metrics for AXGN.
What is the Short Interest ratio of AXOGEN INC (AXGN) stock?
The outstanding short interest for AXOGEN INC (AXGN) is 4.62% of its float. Check the ownership tab for more information on the AXGN short interest.
AXGN Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to AXGN. When comparing the yearly performance of all stocks, AXGN is one of the better performing stocks in the market, outperforming 98.34% of all stocks.
AXGN Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AXGN. AXGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AXGN Financial Highlights
Over the last trailing twelve months AXGN reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS increased by 172.22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.89% | ||
| ROE | -9.59% | ||
| Debt/Equity | 0.46 |
AXGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to AXGN. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 119.69% and a revenue growth 16.31% for AXGN